Rafferty Asset Management

Rafferty Asset Management’s Lyell Immunopharma LYEL Stock Holding History

Rafferty Asset Management’s Portfolio LYEL Stock Details LYEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-21,244	Closed	-$625K	–	1087
2023 Q3	$625K	Buy	21,244 +4,980	+31%	+$236K	﹤0.01%	884
2023 Q2	$1.03M	Sell	16,264 -9,050	-36%	-$501K	0.01%	810
2023 Q1	$1.19M	Sell	25,314 -3,754	-13%	-$201K	0.01%	757
2022 Q4	$2.02M	Buy	29,068 +18,748	+182%	+$1.86M	0.02%	576
2022 Q3	$1.51M	Buy	+10,320	New	+$1.4M	0.02%	572

Other funds holding LYEL

MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

WuXi AppTec Shanghai, China $19M AUM 20.22% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return